Zenas BioPharma raises $118m Series B round to advance pipeline

Zenas BioPharma raises $118m Series B round to advance pipeline

Photo by Hal Gatewood on Unsplash

10 November, 2022

biopharmaceutical Enavate Sciences Quan Capital therapies Vivo Capital Zenas BioPharma

Printed by Unregistered user on Tue, 23 Dec 2025 23:53:14 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Vietnam sees big rise in chain drugstores during pandemic

Thousand Oaks Biopharma nets $236m led by China's Goldstone, CDH unit

Read more from Greater China

China’s LandSpace completes ‘tutoring’ process ahead of Shanghai IPO

Policy & Regulations

US bars approvals of new models of China’s DJI, other foreign drones